Circulating Tumor cells detection by liquid biopsy during early-stage cervical cancer surgery: a pilot study

The Invisible Invaders and the Bloodstream Highway

Imagine your body as a bustling, high-security city. Usually, the walls are strong, and the guards (your immune system) keep things in order. But sometimes, a few rogue cells decide to break the rules. These are cancer cells. In the worst-case scenario, they don't just stay in their neighborhood; they hop onto the bloodstream highway, travel to other parts of the city, and start new, dangerous colonies. This is how cancer spreads, or "metastasizes," and it's the main reason why some cancers come back even after surgery seems to have removed everything.

For a long time, doctors have had a hard time catching these "rogue cells" while they are still on the move. They are like tiny spies hiding in a massive ocean of blood. To find them, scientists use a technique called a "liquid biopsy." Instead of cutting into the body to look for a tumor, they take a drop of blood and scan it for these invisible invaders, known as Circulating Tumor Cells (CTCs). If they can catch these cells early, especially while a patient is undergoing surgery, it might give doctors a superpower: the ability to see if the surgery accidentally shook loose more spies than expected, or if the cancer is already trying to escape. This is the big question scientists are asking: Does the act of operating on a tumor make it easier for these cells to slip into the blood?

---

The Surgery Experiment: Catching the Spies in the Act

A team of researchers in France decided to play detective during a very specific kind of operation. They were looking at patients with early-stage cervical cancer (a type of cancer affecting the neck of the uterus). These patients were scheduled for a minimally invasive surgery called a laparoscopy, where doctors use tiny cameras and tools to remove the tumor through small holes in the belly, rather than making one big cut.

The scientists had a hunch that the surgery itself might be a bit like shaking a snow globe. When you shake a snow globe, the snowflakes fly everywhere. They wondered: when surgeons manipulate the tumor or pump carbon dioxide gas into the belly to make room to work (a process called pneumoperitoneum), does it knock loose some of those sneaky cancer cells and send them swirling into the patient's bloodstream?

To find out, they set up a "blood sampling game" with 11 brave volunteers. They took blood samples at three critical moments:

1. Before the show starts (T0): Just before the patient went into the operating room.
2. After the gas is pumped in (T1): Once the belly was inflated with CO₂ but before they touched the tumor.
3. Right before the final cut (T2): Just before they removed the uterus, after they had finished moving things around.

They used a high-tech machine called the CellSearch® system to hunt for the CTCs. Think of this machine as a super-sensitive metal detector that only beeps for specific types of cells that look like cancer cells but aren't white blood cells.

What They Found: The Snow Globe Shook a Little

The results were a mix of "nothing to see here" and "whoa, look at that!"

First, the good news for the "before" sample: Zero cancer cells were found in the blood of any patient before the surgery started. It seems that in these early stages, the cancer was staying put, not swimming around in the blood yet.

However, once the surgery began, the story changed. The "snow globe" effect seemed real, but only for a few people.

• 3 out of 11 patients (about 27%) showed up with cancer cells in their blood during the operation.
• One patient had 2 cells appear right after the gas was pumped in.
• Two other patients had cells appear just before the uterus was removed. One of these patients had a massive burst of at least 50 cells, while the other had 2.

It's important to note that these cells were only found during the surgery. They weren't there before, and the study didn't track them long after to see if they stayed. The researchers also checked the removed tissue and found that in 3 of the 11 patients, there was still some tiny bit of cancer left behind (residual tumor), even though the surgeons thought they got it all. Interestingly, one of the patients who had cancer cells in their blood also had this leftover tumor.

The Aftermath: Did the Spies Win?

The researchers didn't stop there. They followed these 11 patients for three years to see if the cancer came back.

• One patient (9.1%) had a recurrence.
• Here is the twist: This was the one patient who had zero cancer cells detected during the surgery.
• The three patients who did have cancer cells in their blood during the operation did not have a recurrence in those three years.

What Does This Mean?

This study is like a pilot test—a small, first step to see if a new idea works. The main takeaway is that it is possible to catch these circulating tumor cells during cervical cancer surgery. The fact that they appeared only during the operation suggests that the surgical process itself might temporarily shake loose some cells.

However, the team is very careful not to call this a "solved mystery." Because the group was so small (only 11 people), they can't say for sure if finding these cells predicts who will get sick again. In fact, the one person who got sick again was the one who didn't have cells in their blood during the surgery, which is confusing and suggests the story is more complicated than just "cells in blood = bad outcome."

The authors suggest that we need to study much larger groups of people to figure out if counting these cells during surgery can help doctors decide on the best treatment. For now, they have proven that the "liquid biopsy" works during the operation, but they haven't yet cracked the code on exactly what those numbers mean for a patient's future. It's a promising clue, but the investigation is far from over.